Trials / Conditions / Furmonertinib
Furmonertinib
3 registered clinical trials studyying Furmonertinib — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis NCT07348965 | Guangzhou University of Traditional Chinese Medicine | N/A |
| Not Yet Recruiting | Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety St NCT07365410 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE) NCT05465343 | Peking Union Medical College | Phase 2 |